Novo Nordisk's stock down 4%
Fri, Jan 17, 2025 9:53 PM

Novo Nordisk's stock down 4%

A Flip by Shubhangi Gupta
Get it on Google Play
The Centers for Medicare and Medicaid Services (CMS) released its second round of drug negotiation targets, a list of 15 drugs under Medicare Part D, including Novo Nordisk's (NVO) blockbuster GLP-1s. Novo was trading down 4% on the news Friday. Diabetes drug Ozempic and weight loss drug Wegovy top the list, along with a number of others like Merck's (MRK) diabetes drug Janumet.

More great flips

Infosys slips 6% post Q3 results, drags down Nifty IT index

Infosys slips 6% post Q3 results, drags down Nifty IT index

Infosys shares tumbled close to 6% on Friday as the company's muted outlook after its third-quarter results prompted investors to cut their bets. While Infosys reported decent numbers, the management expects a muted fourth quarter which led to the slide in the stock, said Dharmesh Kant, head of research, Cholamandalam Securities.

Open Flip
Axis Bank Shares Slump Over 4%

Axis Bank Shares Slump Over 4%

Axis Bank's shares fell 4.4% to ₹992 after the lender posted weaker-than-expected earnings in its December quarter, driven by higher credit costs and loan book concerns. The Bank Nifty index also declined 1.5%, with most of its constituents falling, as investors remain cautious on Axis Bank's inconsistent quarterly numbers and growth prospects.

Open Flip
Motilal Oswal sees 30% growth for BEL stock, gives Rs 360 target

Motilal Oswal sees 30% growth for BEL stock, gives Rs 360 target

Expecting Bharat Electronics’ (BEL) market share to grow in the coming years, domestic brokerage firm Motilal Oswal has shared its optimistic view on the stock, maintaining a ‘buy’ rating on the same with a target price of Rs 360, indicating potential growth of 27.5%. The shares of BEL closed 2.2% higher at Rs 282.15 on the BSE today.

Open Flip

Join our Smart Investment Community

More than 2 Million users are using FlipItMoney to stay updated about the business and finance world! Join FlipItMoney now and take smart investment decisions!
Icon